Clinical and microbiological evaluation of hemodialysis-associated pneumonia (HDAP): should HDAP be included in healthcare-associated pneumonia? 2011

Satoshi Kawasaki, and Nobuki Aoki, and Hiroshi Kikuchi, and Hitoshi Nakayama, and Noriko Saito, and Hisaki Shimada, and Shigeru Miyazaki, and Shinji Sakai, and Masashi Suzuki, and Ichiei Narita
Department of Respirology, Shinrakuen Hospital, 3-3-11 Shindori-minami, Nishi-ku, Niigata 950-2087, Japan. satoshi3231kawasaki@yahoo.co.jp

Although hemodialysis-associated pneumonia (HDAP) was included among the healthcare-associated pneumonias (HCAP) in the 2005 American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) guideline, little information relevant to clinical epidemiology, especially microbiological characteristics, is available. This study aimed to reveal microbiological characteristics and clinical outcomes of HDAP and to assess whether HDAP should be included in the HCAP category. We retrospectively analyzed 69 HDAP patients [42 with moderate and 27 with severe disease based on A-DROP (age, dehydration, respiratory failure, orientation disturbance, and low blood pressure)] in whom sputum cultures were performed at our hospital between 2007 and 2009. The most common pathogens were Staphylococcus aureus (37.7%), which were composed of methicillin-resistant S. aureus (MRSA) (27.5%) and methicillin-sensitive S. aureus (MSSA) (10.1%), followed by Streptococcus pneumoniae (10.1%), Klebsiella pneumoniae (8.7%), Haemophilus influenzae (7.2%), and Moraxella catarrhalis (5.8%). This distribution mostly resembled the microbiological characteristics of HCAP reported previously, except that the frequency of multi-drug-resistant (MDR) gram negatives such as Pseudomonas aeruginosa (2.9%) was clearly lower and that of MRSA was higher. There were no significant differences in microbiological findings, including the incidence of MDR pathogens, between the two severity groups. Despite most cases (82.6%) receiving only monotherapy, the prognosis (30-day survival and in-hospital mortality rates were 88.4% and, 17.4%, respectively) was similar to the past HCAP reports, but there were no significant correlations between prognosis and presence of MDR pathogens (30-day mortality rates 18.2% in MDR positive vs. 8.5% in MDR negative; p = 0.242). Assessment for not only MDR pathogens, but also severity of illness by the A-DROP system made it possible to conduct stratification based on prognosis. Our results suggest that HDAP should be included in the HCAP category, while understanding that there are some differences.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D005260 Female Females
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Satoshi Kawasaki, and Nobuki Aoki, and Hiroshi Kikuchi, and Hitoshi Nakayama, and Noriko Saito, and Hisaki Shimada, and Shigeru Miyazaki, and Shinji Sakai, and Masashi Suzuki, and Ichiei Narita
April 2006, Current opinion in infectious diseases,
Satoshi Kawasaki, and Nobuki Aoki, and Hiroshi Kikuchi, and Hitoshi Nakayama, and Noriko Saito, and Hisaki Shimada, and Shigeru Miyazaki, and Shinji Sakai, and Masashi Suzuki, and Ichiei Narita
June 2006, Medicina clinica,
Satoshi Kawasaki, and Nobuki Aoki, and Hiroshi Kikuchi, and Hitoshi Nakayama, and Noriko Saito, and Hisaki Shimada, and Shigeru Miyazaki, and Shinji Sakai, and Masashi Suzuki, and Ichiei Narita
February 2011, Alzheimer's research & therapy,
Satoshi Kawasaki, and Nobuki Aoki, and Hiroshi Kikuchi, and Hitoshi Nakayama, and Noriko Saito, and Hisaki Shimada, and Shigeru Miyazaki, and Shinji Sakai, and Masashi Suzuki, and Ichiei Narita
January 1995, Nordisk medicin,
Satoshi Kawasaki, and Nobuki Aoki, and Hiroshi Kikuchi, and Hitoshi Nakayama, and Noriko Saito, and Hisaki Shimada, and Shigeru Miyazaki, and Shinji Sakai, and Masashi Suzuki, and Ichiei Narita
November 2017, Journal of biomedical research,
Satoshi Kawasaki, and Nobuki Aoki, and Hiroshi Kikuchi, and Hitoshi Nakayama, and Noriko Saito, and Hisaki Shimada, and Shigeru Miyazaki, and Shinji Sakai, and Masashi Suzuki, and Ichiei Narita
October 2018, BMJ (Clinical research ed.),
Satoshi Kawasaki, and Nobuki Aoki, and Hiroshi Kikuchi, and Hitoshi Nakayama, and Noriko Saito, and Hisaki Shimada, and Shigeru Miyazaki, and Shinji Sakai, and Masashi Suzuki, and Ichiei Narita
December 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Satoshi Kawasaki, and Nobuki Aoki, and Hiroshi Kikuchi, and Hitoshi Nakayama, and Noriko Saito, and Hisaki Shimada, and Shigeru Miyazaki, and Shinji Sakai, and Masashi Suzuki, and Ichiei Narita
January 1993, The Journal of neuropsychiatry and clinical neurosciences,
Satoshi Kawasaki, and Nobuki Aoki, and Hiroshi Kikuchi, and Hitoshi Nakayama, and Noriko Saito, and Hisaki Shimada, and Shigeru Miyazaki, and Shinji Sakai, and Masashi Suzuki, and Ichiei Narita
May 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Satoshi Kawasaki, and Nobuki Aoki, and Hiroshi Kikuchi, and Hitoshi Nakayama, and Noriko Saito, and Hisaki Shimada, and Shigeru Miyazaki, and Shinji Sakai, and Masashi Suzuki, and Ichiei Narita
October 2021, Deutsches Arzteblatt international,
Copied contents to your clipboard!